A double-blind, randomized, placebo-controlled, cross-over, allergen challenge study to evaluate taste and local tolerance of NLA nasal spray in patients with allergic rhinitis
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2008
At a glance
- Drugs Cetirizine (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions
- 04 Mar 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 06 Oct 2007 New trial record.